CBD is the most commonly recommended cannabinoid for the elderly, and other patients who must remain alert in their activities because it is non-psychoactive, which means it does not produce euphoria or the sensation of being "high."

Cannabigerol, or CBG, is a non-psychoactive cannabinoid found in high-CBD and low-THC cannabis strains, including hemp. CBG, like THC, binds to cannabinoid receptors in the brain.

CBG, on the other hand, acts as a buffer to THC's psychoactivity by alleviating the paranoia that can be caused by higher levels of THC.

Delta-8 users report similar effects to THC, such as happiness, uplifting feelings, and relief from some symptoms such as pain, despite the fact that the compound is much less potent.

THC-like side effects include dry mouth, red eyes, munchies, short-term memory loss, paranoia, and anxiety. It's important to note that delta-8 hasn't been thoroughly researched, and more research on its effects on the mind and body is needed.

THCp is a rare, naturally occurring cannabinoid that is thought to be up to 33 times more potent than THC on CB1 receptors and up to 10 times more active on CB2 receptors than THC.

THCp has a distinct effect when combined with Delta 8 THC, which sets it apart from other cannabinoids.